RIZZARI, CARMELO

RIZZARI, CARMELO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 106 (tempo di esecuzione: 0.037 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Hypersensitivity Reactions to Native E. coli L-asparaginase in Children with Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction 01 - Articolo su rivista 2023 Rizzari C.Biondi A.Valsecchi MG. +
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL 01 - Articolo su rivista 2023 Rizzari C. +
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children with Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol 01 - Articolo su rivista 2023 Rizzari C.Valsecchi M. G.Biondi A. +
Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers 01 - Articolo su rivista 2022 Rizzari C. +
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO 01 - Articolo su rivista 2022 Molinaro A.Zanta D.Rizzari C.Biondi A. +
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study 01 - Articolo su rivista 2022 Rizzari C. +
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) 01 - Articolo su rivista 2022 Biondi, AndreaValsecchi, Maria GraziaRizzari, CarmeloConter, ValentinoCazzaniga, Giovanni +
Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war 01 - Articolo su rivista 2022 Rizzari C. +
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach 01 - Articolo su rivista 2022 Rizzari C. +
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial 01 - Articolo su rivista 2022 Rizzari C. +
Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child 01 - Articolo su rivista 2022 Faraguna M. C.Musto F.Crescitelli V.Fedeli T.Kullmann G.Cattoni A.Dell'acqua F.Rizzari C. +
NUP214–ABL1 fusion in childhood T-ALL 01 - Articolo su rivista 2022 Rizzari C.Valsecchi M. G. +
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 01 - Articolo su rivista 2022 Brivio, EricaCossio, AndreaPrunotto, GiuliaRizzari, CarmeloBiondi, AndreaConter, ValentinoValsecchi, Maria GraziaBalduzzi, Adriana +
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 01 - Articolo su rivista 2022 Fazio, GraziaQuadri, ManuelSaitta, ClaudiaPalmi, ChiaraBardini, MichelaGrioni, AndreaSavino, Angela MariaConter, ValentinoRizzari, CarmeloValsecchi, Maria GraziaBiondi, AndreaCazzaniga, Giovanni +
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product 01 - Articolo su rivista 2022 Bettini L. R.Amoroso A.Rizzari C. +
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia 01 - Articolo su rivista 2022 Rizzari C.Conter V. +
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study 01 - Articolo su rivista 2022 Rizzari C. +
The impact of the EU General Data Protection Regulation on childhood cancer research in Europe 01 - Articolo su rivista 2022 Rizzari C. +
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 01 - Articolo su rivista 2021 Saettini F.Castelli I.Fazio G.Quadri M.Cazzaniga G.Balduzzi A. C.Biondi A.Rizzari C.Bonanomi S. +
A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety 01 - Articolo su rivista 2021 Rizzari C. +